Response by Morphology
| Response . | Non-PB N (%) . | PB N (%) . | Total . |
|---|---|---|---|
| Objective | 281 (69.2) | 21 (58.3) | 302 |
| No change | 77 (19.0) | 4 (11.1) | 81 |
| Progression | 48 (11.8)† | 11 (30.6)† | 59 |
| Total* | 406 (100) | 36 (100) | 442 |
| Response . | Non-PB N (%) . | PB N (%) . | Total . |
|---|---|---|---|
| Objective | 281 (69.2) | 21 (58.3) | 302 |
| No change | 77 (19.0) | 4 (11.1) | 81 |
| Progression | 48 (11.8)† | 11 (30.6)† | 59 |
| Total* | 406 (100) | 36 (100) | 442 |
*Eleven patients were unevaluable for response (10 from the non-PB and 1 from the PB group).
Reflect a statistically significant difference, P < .0001.